Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

I-MAB Says Will Continue To Review Follow-Up Data From The Phase 2 Study Of Lemzoparlimab In HR-MDS; AbbVie Terminating Agreement Relating To Certain CD47 Antibody Compounds And Products

Author: Benzinga Newsdesk | September 22, 2023 04:13pm

- Reuters

Posted In: ABBV IMAB